We have failed to fail’: Merck gambles $250M cash on a next-gen approach to mRNA — after punting its big alliance with Moderna

August 16, 2022 – Its partner of choice now: Orna Therapeutics, which has forged its classic, validating Big Pharma alliance in a deal that delivers $150 million in cash with a $3.5 billion smorgasbord of milestones.